None listed
Conditions
Brief summary
The patients with chronic heart failure (CHF) suffer from low exercise tolerance, dyspnea and increased fatigue. The quality of life is very low because of the symptoms accompanying the CHF. The methodology of respiration therapy by means of any expiratory aids in patients with CHF has not yet been described in foreign countries. The expiratory muscle training with the treshold PEP device at home will lead to the improvement of the quality of life. The main intention of this study is to find a way how to effectively, cheaply and easily minimize the consecuences of heart failure.
Interventions
The patient was advised to undertake a 10 week expiratory muscles training program with Threshold Positive expiratory preassure (Treshold PEP), which he was taught by a physiotherapist in the hospital and with which he continued at home. The Treshold PEP is a small respiratory device to which the patient breathes against resistance and strenghtens his expiratory muscles. This device is advised to be used half an hour every day for the duration of 10 weeks. Every patient recieves a plan based on their initial examination results. All patients, who refused expiratory muscle training were, with approval, included in the control group - it is consecutive group of patients. These patients went through identical initial and leaving examinations: anamnesis, clinical examination, spirometry, plethysmography, blood gas levels were determined and the patients also completed the modified Medical Research Council dyspnea questionnaires. A six-minute walk test (6-MWT) was performed with patients, also, the chest parameters in the mesosternale and xiphosternale level were measured.
Sponsors
Study design
Eligibility
Inclusion criteria
systolic heart failure all etiology New York Heart Association (NYHA) II-III ejection fraction of the left ventricle (EF LV) less than 45% patients without lung diseases
Exclusion criteria
The patients can not have uncompensated heart failure, chronic lung disease or change of medication during the intervention.